What is the role of fully covered colonic stents in the treatment of benign colonic strictures?

Role of Fully Covered Colonic Stents in Benign Colonic Strictures

Fully covered self-expanding metal stents (FCSEMS) are a reasonable therapeutic option for benign colonic strictures, particularly anastomotic strictures, with clinical success rates of 62-81%, though they are limited by high migration rates (63%) and symptom recurrence (53%).

Primary Indication and Efficacy

FCSEMS serve as a bridge therapy for benign colonic strictures when traditional endoscopic balloon dilation has failed. The evidence demonstrates:

• Clinical success rates range from 62-81% across multiple studies, with successful colonic decompression achieved within 48 hours in most cases 1, 2
• Complete resolution of anastomotic strictures or leaks was achieved in all patients in one series of 8 patients 3
• The stents are particularly effective for anastomotic strictures (the most common indication), anastomotic leaks, and combined stricture-leak scenarios 1

Critical Limitation: Migration

Stent migration is the predominant complication, occurring in 63% of cases in the largest series 2. This represents the major technical challenge limiting long-term success:

• Migration typically occurs within the first 2 weeks of placement 3
• Stents wider than 20 mm migrate significantly less often - this is the only modifiable factor identified to reduce migration 2
• When migration occurs, replacement with a larger 23 mm stent may be necessary 3

Optimal Stent Duration and Recurrence

The evidence supports a specific timeframe for stent placement:

• Optimal duration is 4-6 weeks (median 21-34 days) before planned removal 1, 2
• Despite initial success, symptom recurrence occurs in 53% of patients regardless of whether migration occurred 2
• When recurrence happens, 37.9% of patients ultimately require alternative interventions including repeat dilations, colostomy, or revisional surgery 1

Technical Considerations

An innovative approach using inverted "upside-down" esophageal FCSEMS showed promise in a small series:

• Prevented migration in 83% of cases (5/6 patients) 4
• The largest end is placed above the stricture to counteract peristaltic forces
• Achieved stricture resolution in all benign cases 4

Clinical Algorithm

For symptomatic benign colonic strictures:

1. First-line: Endoscopic balloon dilation
2. After failed dilation (≥10 weeks of persistent stricture): Consider FCSEMS placement
3. Stent selection: Use stents >20 mm diameter to minimize migration 2
4. Duration: Plan removal at 4-6 weeks 1, 2
5. Follow-up: Monitor at 3 months for recurrence 3
6. If recurrence: Consider repeat stenting, continued dilations, or surgical revision based on technical feasibility 1

Safety Profile

Complications beyond migration include:

• Minor: Abdominal/rectal pain (common), transient fever, tenesmus 1
• Major: Colonic perforation at insertion (rare), ulceration, granulation tissue formation 5, 1
• Overall, the procedure is safe with high technical success (100% in most series) 3, 2

Important Caveats

• FCSEMS should be viewed as temporizing rather than definitive therapy given the 53% recurrence rate 2
• The evidence base consists primarily of small retrospective series; no high-quality randomized trials exist for benign colonic strictures
• Careful patient selection is essential - those with complete anastomotic closure or complex fistulizing disease may have lower success rates 1
• The 2021 AGA guideline addresses FCSEMS only for malignant obstructions, not benign strictures, reflecting the limited evidence base for benign indications 6